Integra Lifesciences Holdings (IART) Accounts Payables (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Accounts Payables of $82.6 million for Q2 2026, down 6.04% sequentially from $87.9 million in Q1 2026, and down 10.99% YoY from $92.8 million in Q2 2025.
Integra Lifesciences Holdings (IART) Accounts Payables (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Accounts Payables for 18 years, with the latest figure at $82.6 million in Q2 2026.
- Quarterly Accounts Payables fell 10.99% year-over-year to $82.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $82.6 million (down 10.99% YoY) and the FY2025 annual result came in at $95.7 million, up 16.03% from the prior year.
- Accounts Payables slipped to $82.6 million in Q2 2026 per IART's latest filing, from $87.9 million in the prior quarter.
- Over five years, Accounts Payables peaked at $112.8 million in Q1 2023 and troughed at $69.5 million in Q2 2022.
- A 5-year average of $91.3 million and a median of $92.3 million in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2024: Accounts Payables soared 65.11% in 2022, then slipped 16.98% in 2024.
- Over 5 years, Accounts Payables stood at $102.1 million in 2022, then declined by 9.57% to $92.3 million in 2023, then slipped by 10.64% to $82.5 million in 2024, then grew by 16.03% to $95.7 million in 2025, then fell by 13.67% to $82.6 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $82.6 million, $87.9 million, and $95.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.28 Bn | 1.01 Bn | 219.74 Mn | 82.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 82.64 Mn |
| Mar 31, 2026 | 87.95 Mn |
| Dec 31, 2025 | 95.73 Mn |
| Sep 30, 2025 | 92.31 Mn |
| Jun 30, 2025 | 92.84 Mn |
| Mar 31, 2025 | 91.30 Mn |
| Dec 31, 2024 | 82.50 Mn |
| Sep 30, 2024 | 77.67 Mn |
| Jun 30, 2024 | 107.49 Mn |
| Mar 31, 2024 | 94.40 Mn |
| Dec 31, 2023 | 92.33 Mn |
| Sep 30, 2023 | 93.55 Mn |
| Jun 30, 2023 | 99.77 Mn |
| Mar 31, 2023 | 112.79 Mn |
| Dec 31, 2022 | 102.10 Mn |
| Sep 30, 2022 | 80.73 Mn |
| Jun 30, 2022 | 69.50 Mn |
| Mar 31, 2022 | 88.37 Mn |
| Dec 31, 2021 | 61.84 Mn |
| Sep 30, 2021 | 59.60 Mn |